Electrical Equipment & Parts
Build Your Comparison
Side-by-side financial analysisStock Comparison
ZOOZ vs MSTR vs SMLR
Revenue, margins, valuation, and 5-year total return — side by side.
Software - Application
Medical - Devices
ZOOZ vs MSTR vs SMLR — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||
|---|---|---|---|
| Industry | Electrical Equipment & Parts | Software - Application | Medical - Devices |
| Market Cap | $45M | $43.79B | $311M |
| Revenue (TTM) | $1M | $490M | $37M |
| Net Income (TTM) | $-69M | $-12.36B | $48M |
| Gross Margin | -268.8% | 68.1% | 90.8% |
| Operating Margin | -26.4% | 94.2% | -94.7% |
| Forward P/E | — | 2.6x | 4.0x |
| Total Debt | $724K | $8.28B | $70K |
| Cash & Equiv. | $27M | $2.30B | $9M |
ZOOZ vs MSTR vs SMLR — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Apr 24 | Jun 26 | Return |
|---|---|---|---|
| ZOOZ Strategy Ltd. (ZOOZ) | 100 | 9.6 | -90.4% |
| Strategy Inc (MSTR) | 100 | 123.1 | +23.1% |
| Semler Scientific, … (SMLR) | 100 | 59.9 | -40.1% |
Price return only. Dividends and distributions are not included.
Quick Verdict: ZOOZ vs MSTR vs SMLR
Each card shows where this stock fits in a portfolio — not just who wins on paper.
ZOOZ is the clearest fit if your priority is sleep-well-at-night and defensive.
- Lower volatility, beta 2.09, Low D/E 0.6%, current ratio 9.85x
- Beta 2.09, current ratio 9.85x
- Beta 2.09 vs SMLR's 3.02
MSTR has the current edge in this matchup, primarily because of its strength in income & stability.
- Dividend streak 1 yrs, beta 2.85, yield 1.0%
- 3.0% revenue growth vs ZOOZ's -76.3%
- Lower P/E (2.6x vs 4.0x)
SMLR is the clearest fit if your priority is growth exposure and long-term compounding.
- Rev growth -17.4%, EPS growth 95.1%, 3Y rev CAGR 2.0%
- 10.8% 10Y total return vs MSTR's 6.1%
- 130.8% margin vs ZOOZ's -52.9%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 3.0% revenue growth vs ZOOZ's -76.3% | |
| Value | Lower P/E (2.6x vs 4.0x) | |
| Quality / Margins | 130.8% margin vs ZOOZ's -52.9% | |
| Stability / Safety | Beta 2.09 vs SMLR's 3.02 | |
| Dividends | 1.0% yield; 1-year raise streak; the other 2 pay no meaningful dividend | |
| Momentum (1Y) | -33.4% vs ZOOZ's -67.3% | |
| Efficiency (ROA) | 8.1% ROA vs ZOOZ's -172.2%, ROIC 13.3% vs -83.0% |
ZOOZ vs MSTR vs SMLR — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
Segment breakdown not available.
ZOOZ vs MSTR vs SMLR — Financial Metrics
Side-by-side numbers across 3 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
SMLR leads in 1 of 6 categories
MSTR leads 1 • ZOOZ leads 0 • 4 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
Evenly matched — MSTR and SMLR each lead in 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
MSTR is the larger business by revenue, generating $490M annually — 376.6x ZOOZ's $1M. SMLR is the more profitable business, keeping 130.8% of every revenue dollar as net income compared to ZOOZ's -52.9%. On growth, MSTR holds the edge at +11.9% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||
|---|---|---|---|
| RevenueTrailing 12 months | $1M | $490M | $37M |
| EBITDAEarnings before interest/tax | -$34M | $480M | -$35M |
| Net IncomeAfter-tax profit | -$69M | -$12.4B | $48M |
| Free Cash FlowCash after capex | -$24M | $7.6B | -$389M |
| Gross MarginGross profit ÷ Revenue | -2.7% | +68.1% | +90.8% |
| Operating MarginEBIT ÷ Revenue | -26.4% | +94.2% | -94.7% |
| Net MarginNet income ÷ Revenue | -52.9% | -25.2% | +130.8% |
| FCF MarginFCF ÷ Revenue | -18.5% | +15.5% | -10.5% |
| Rev. Growth (YoY)Latest quarter vs prior year | -100.0% | +11.9% | -44.6% |
| EPS Growth (YoY)Latest quarter vs prior year | -11.9% | -132.0% | +48.6% |
Valuation Metrics
Evenly matched — ZOOZ and MSTR and SMLR each lead in 1 of 3 comparable metrics.
Valuation Metrics
| Metric | |||
|---|---|---|---|
| Market CapShares × price | $45M | $43.8B | $311M |
| Enterprise ValueMkt cap + debt − cash | $19M | $49.8B | $302M |
| Trailing P/EPrice ÷ TTM EPS | -0.52x | -8.61x | 3.96x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 2.62x | — |
| PEG RatioP/E ÷ EPS growth rate | — | — | 0.18x |
| EV / EBITDAEnterprise value multiple | — | — | 14.04x |
| Price / SalesMarket cap ÷ Revenue | 184.00x | 91.76x | 5.52x |
| Price / BookPrice ÷ Book value/share | 0.24x | 0.76x | 0.70x |
| Price / FCFMarket cap ÷ FCF | — | — | — |
Profitability & Efficiency
SMLR leads this category, winning 6 of 9 comparable metrics.
Profitability & Efficiency
SMLR delivers a 10.5% return on equity — every $100 of shareholder capital generates $11 in annual profit, vs $-2 for ZOOZ. SMLR carries lower financial leverage with a 0.00x debt-to-equity ratio, signaling a more conservative balance sheet compared to MSTR's 0.16x. On the Piotroski fundamental quality scale (0–9), ZOOZ scores 5/9 vs MSTR's 3/9, reflecting solid financial health.
| Metric | |||
|---|---|---|---|
| ROE (TTM)Return on equity | -2.0% | -24.1% | +10.5% |
| ROA (TTM)Return on assets | -172.2% | -19.4% | +8.1% |
| ROICReturn on invested capital | -83.0% | -9.9% | +13.3% |
| ROCEReturn on capital employed | -83.5% | -12.6% | +13.7% |
| Piotroski ScoreFundamental quality 0–9 | 5 | 3 | 4 |
| Debt / EquityFinancial leverage | 0.01x | 0.16x | 0.00x |
| Net DebtTotal debt minus cash | -$26M | $6.0B | -$9M |
| Cash & Equiv.Liquid assets | $27M | $2.3B | $9M |
| Total DebtShort + long-term debt | $724,000 | $8.3B | $70,000 |
| Interest CoverageEBIT ÷ Interest expense | -11.31x | 9.05x | -12.85x |
Total Returns (Dividends Reinvested)
Evenly matched — MSTR and SMLR each lead in 3 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in MSTR five years ago would be worth $20,799 today (with dividends reinvested), compared to $684 for ZOOZ. Over the past 12 months, SMLR leads with a -33.4% total return vs ZOOZ's -67.3%. The 3-year compound annual growth rate (CAGR) favors MSTR at 67.7% vs ZOOZ's -59.1% — a key indicator of consistent wealth creation.
| Metric | |||
|---|---|---|---|
| YTD ReturnYear-to-date | -42.7% | -16.6% | +14.3% |
| 1-Year ReturnPast 12 months | -67.3% | -65.7% | -33.4% |
| 3-Year ReturnCumulative with dividends | -93.2% | +371.9% | -20.2% |
| 5-Year ReturnCumulative with dividends | -93.2% | +108.0% | -81.2% |
| 10-Year ReturnCumulative with dividends | -93.2% | +609.3% | +1075.1% |
| CAGR (3Y)Annualised 3-year return | -59.1% | +67.7% | -7.3% |
Risk & Volatility
Evenly matched — ZOOZ and SMLR each lead in 1 of 2 comparable metrics.
Risk & Volatility
ZOOZ is the less volatile stock with a 2.09 beta — it tends to amplify market swings less than SMLR's 3.02 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. SMLR currently trades 41.7% from its 52-week high vs ZOOZ's 5.5% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||
|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 2.09x | 2.85x | 3.02x |
| 52-Week HighHighest price in past year | $101.20 | $457.22 | $48.77 |
| 52-Week LowLowest price in past year | $0.47 | $104.17 | $14.88 |
| % of 52W HighCurrent price vs 52-week peak | +5.5% | +28.7% | +41.7% |
| RSI (14)Momentum oscillator 0–100 | 42.9 | 37.2 | 52.4 |
| Avg Volume (50D)Average daily shares traded | 159K | 16.4M | 0 |
Analyst Outlook
MSTR leads this category, winning 1 of 1 comparable metric.
Analyst Outlook
Analyst consensus: MSTR as "Buy", SMLR as "Buy". Consensus price targets imply 148.4% upside for SMLR (target: $51) vs 91.9% for MSTR (target: $252). MSTR is the only dividend payer here at 0.99% yield — a key consideration for income-focused portfolios.
| Metric | |||
|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Buy | Buy |
| Price TargetConsensus 12-month target | — | $251.60 | $50.50 |
| # AnalystsCovering analysts | — | 29 | 7 |
| Dividend YieldAnnual dividend ÷ price | — | +1.0% | — |
| Dividend StreakConsecutive years of raises | 0 | 1 | — |
| Dividend / ShareAnnual DPS | — | $1.30 | — |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | 0.0% | 0.0% |
SMLR leads in 1 of 6 categories (Profitability & Efficiency). MSTR leads in 1 (Analyst Outlook). 4 tied.
ZOOZ vs MSTR vs SMLR: Key Questions Answered
9 questions · data-driven answers · updated daily
01Is ZOOZ or MSTR or SMLR a better buy right now?
For growth investors, Strategy Inc (MSTR) is the stronger pick with 3.
0% revenue growth year-over-year, versus -76. 3% for ZOOZ Strategy Ltd. (ZOOZ). Semler Scientific, Inc. (SMLR) offers the better valuation at 4. 0x trailing P/E, making it the more compelling value choice. Analysts rate Strategy Inc (MSTR) a "Buy" — based on 29 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which is the better long-term investment — ZOOZ or MSTR or SMLR?
Over the past 5 years, Strategy Inc (MSTR) delivered a total return of +108.
0%, compared to -93. 2% for ZOOZ Strategy Ltd. (ZOOZ). Over 10 years, the gap is even starker: SMLR returned +1075% versus ZOOZ's -93. 2%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
03Which is safer — ZOOZ or MSTR or SMLR?
By beta (market sensitivity over 5 years), ZOOZ Strategy Ltd.
(ZOOZ) is the lower-risk stock at 2. 09β versus Semler Scientific, Inc. 's 3. 02β — meaning SMLR is approximately 44% more volatile than ZOOZ relative to the S&P 500. On balance sheet safety, Semler Scientific, Inc. (SMLR) carries a lower debt/equity ratio of 0% versus 16% for Strategy Inc — giving it more financial flexibility in a downturn.
04Which is growing faster — ZOOZ or MSTR or SMLR?
By revenue growth (latest reported year), Strategy Inc (MSTR) is pulling ahead at 3.
0% versus -76. 3% for ZOOZ Strategy Ltd. (ZOOZ). On earnings-per-share growth, the picture is similar: Semler Scientific, Inc. grew EPS 95. 1% year-over-year, compared to -886. 2% for ZOOZ Strategy Ltd.. Over a 3-year CAGR, SMLR leads at 2. 0% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
05Which has better profit margins — ZOOZ or MSTR or SMLR?
Semler Scientific, Inc.
(SMLR) is the more profitable company, earning 72. 7% net margin versus -225. 1% for ZOOZ Strategy Ltd. — meaning it keeps 72. 7% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: SMLR leads at 37. 2% versus -215. 1% for ZOOZ. At the gross margin level — before operating expenses — SMLR leads at 91. 5%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
06Is ZOOZ or MSTR or SMLR more undervalued right now?
Analyst consensus price targets imply the most upside for SMLR: 148.
4% to $50. 50.
07Which pays a better dividend — ZOOZ or MSTR or SMLR?
In this comparison, MSTR (1.
0% yield) pays a dividend. ZOOZ, SMLR do not pay a meaningful dividend and should not be held primarily for income.
08Is ZOOZ or MSTR or SMLR better for a retirement portfolio?
For long-horizon retirement investors, Strategy Inc (MSTR) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (1.
0% yield, +609. 3% 10Y return). ZOOZ Strategy Ltd. (ZOOZ) carries a higher beta of 2. 09 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (MSTR: +609. 3%, ZOOZ: -93. 2%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
09What are the main differences between ZOOZ and MSTR and SMLR?
These companies operate in different sectors (ZOOZ (Industrials) and MSTR (Technology) and SMLR (Healthcare)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: ZOOZ is a small-cap quality compounder stock; MSTR is a mid-cap quality compounder stock; SMLR is a small-cap deep-value stock. MSTR pays a dividend while ZOOZ, SMLR do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.